Confronta i metodi
Esamina i metodi selezionati fianco a fianco; le righe che differiscono sono evidenziate.
| Metodo Chou-Talalay× | Analisi di Schild× | |
|---|---|---|
| Campo | Farmacologia | Farmacologia |
| Famiglia | Process / pipeline | Process / pipeline |
| Anno di origine≠ | 1983 | 1947 |
| Ideatore≠ | Ting-Chao Chou and Paul Talalay | Henry Schild |
| Tipo≠ | synergy quantification | antagonism quantification |
| Fonte seminale≠ | Chou, T. C., & Talalay, P. (1983). Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Advances in Enzyme Regulation, 22, 27-55. DOI ↗ | Schild, H. O. (1947). pA, a new scale for the measurement of drug antagonism. Journal of Physiology, 106(3), 337-357. DOI ↗ |
| Alias≠ | CI method, Chou method, median-effect analysis | Schild plot, pA2 |
| Correlati | 3 | 3 |
| Sintesi≠ | The Chou-Talalay method is a quantitative framework for analyzing drug interactions, developed by Ting-Chao Chou and Paul Talalay in 1983. It combines median-effect principle with the combination index (CI) to provide rigorous, model-independent assessment of synergistic, additive, or antagonistic drug effects. | Schild analysis is a quantitative method for characterizing competitive receptor antagonism developed by Henry Schild in 1947. It uses dose-response curves in the presence and absence of antagonist to estimate the antagonist affinity constant (pA2), enabling standardized comparison of antagonist potency across drugs and experimental systems. |
| ScholarGateInsieme di dati ↗ |
|
|